Business Description
Microbix Biosystems Inc
NAICS : 325410
SIC : 3741
ISIN : CA59501P1045
Total Employee Number:
130Description
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.2 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -2.29 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 1.45 | |||||
Beneish M-Score | -2.04 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.2 | |||||
3-Year EBITDA Growth Rate | -51.3 | |||||
3-Year Book Growth Rate | 3.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.02 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 30.73 | |||||
9-Day RSI | 41.09 | |||||
14-Day RSI | 46.76 | |||||
3-1 Month Momentum % | 17.65 | |||||
6-1 Month Momentum % | 36.36 | |||||
12-1 Month Momentum % | 1.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.35 | |||||
Quick Ratio | 2.91 | |||||
Cash Ratio | 1.97 | |||||
Days Inventory | 391.73 | |||||
Days Sales Outstanding | 67.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 0.64 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.48 | |||||
Operating Margin % | -33.4 | |||||
Net Margin % | -38.62 | |||||
EBITDA Margin % | -20.01 | |||||
FCF Margin % | -37.08 | |||||
OCF Margin % | -32.07 | |||||
ROE % | -20.44 | |||||
ROA % | -15.3 | |||||
ROIC % | -20.31 | |||||
3-Year ROIIC % | -73.56 | |||||
ROC (Joel Greenblatt) % | -24.3 | |||||
ROCE % | -13.97 | |||||
Years of Profitability over Past 10-Year | 5 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 4.21 | |||||
PS Ratio | 2.78 | |||||
PB Ratio | 1.62 | |||||
Price-to-Tangible-Book | 1.84 | |||||
EV-to-EBIT | -8.17 | |||||
EV-to-EBITDA | -13.23 | |||||
EV-to-Revenue | 2.65 | |||||
EV-to-Forward-Revenue | 1.91 | |||||
EV-to-FCF | -7.14 | |||||
Price-to-GF-Value | 1.13 | |||||
Price-to-Projected-FCF | 2.46 | |||||
Price-to-Median-PS-Value | 1.18 | |||||
| Price-to-Net-Current-Asset-Value | 3.28 | |||||
Earnings Yield (Greenblatt) % | -12.24 | |||||
FCF Yield % | -13.54 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Microbix Biosystems Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 14.813 | ||
| EPS (TTM) (C$) | -0.041 | ||
| Beta | 0.7192 | ||
| 3-Year Sharpe Ratio | -0.07 | ||
| 3-Year Sortino Ratio | -0.12 | ||
| Volatility % | 36.22 | ||
| 14-Day RSI | 46.76 | ||
| 14-Day ATR (C$) | 0.007362 | ||
| 20-Day SMA (C$) | 0.30325 | ||
| 12-1 Month Momentum % | 1.69 | ||
| 52-Week Range (C$) | 0.21 - 0.32 | ||
| Shares Outstanding (Mil) | 137.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Microbix Biosystems Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Microbix Biosystems Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Microbix Biosystems Inc Frequently Asked Questions
What is Microbix Biosystems Inc(TSX:MBX)'s stock price today?
The current price of TSX:MBX is C$0.30. The 52 week high of TSX:MBX is C$0.32 and 52 week low is C$0.21.
When is next earnings date of Microbix Biosystems Inc(TSX:MBX)?
The next earnings date of Microbix Biosystems Inc(TSX:MBX) is .
Does Microbix Biosystems Inc(TSX:MBX) pay dividends? If so, how much?
Microbix Biosystems Inc(TSX:MBX) does not pay dividend.
Press Release
Articles on Microbix Biosystems Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers